You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LRMR Buy Disclosure
Hamilton Thomas Edward · SEC Form 4 · Filed Nov 12, 2026
Buy
Calculated transaction value
$187.08K
Hamilton Thomas Edward Director
LRMR
Larimar Therapeutics
LRMR
Transaction date
Nov 12, 2026
Public filing date
Nov 12, 2026
Filing lag
Filed same day
LRMR daily price context
Close on/before transaction
$2.7
Nov 12, 2026
First close after public filing
$3.02
Nov 13, 2026
Return after filing · so far
-0.99%
Through Nov 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 70,000 shares @ $2.67
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001193125-26-459008
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$187.08K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Larimar Therapeutics, Inc. LRMR Current | Buy | Nov 12, 2026 | $187.08K |